178 related articles for article (PubMed ID: 21647300)
1. Histone deacetylase inhibition redistributes topoisomerase IIβ from heterochromatin to euchromatin.
Cowell IG; Papageorgiou N; Padget K; Watters GP; Austin CA
Nucleus; 2011; 2(1):61-71. PubMed ID: 21647300
[TBL] [Abstract][Full Text] [Related]
2. Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases.
Bártová E; Pacherník J; Harnicarová A; Kovarík A; Kovaríková M; Hofmanová J; Skalníková M; Kozubek M; Kozubek S
J Cell Sci; 2005 Nov; 118(Pt 21):5035-46. PubMed ID: 16254244
[TBL] [Abstract][Full Text] [Related]
3. Interaction with members of the heterochromatin protein 1 (HP1) family and histone deacetylation are differentially involved in transcriptional silencing by members of the TIF1 family.
Nielsen AL; Ortiz JA; You J; Oulad-Abdelghani M; Khechumian R; Gansmuller A; Chambon P; Losson R
EMBO J; 1999 Nov; 18(22):6385-95. PubMed ID: 10562550
[TBL] [Abstract][Full Text] [Related]
4. Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments.
Karagiannis TC; Harikrishnan KN; El-Osta A
Oncogene; 2007 Jun; 26(27):3963-71. PubMed ID: 17213813
[TBL] [Abstract][Full Text] [Related]
5. Histone Deacetylase Inhibitors Trichostatin A and MCP30 Relieve Benzene-Induced Hematotoxicity via Restoring Topoisomerase IIα.
Chen J; Zheng Z; Chen Y; Li J; Qian S; Shi Y; Sun L; Han Y; Zhang S; Yu K
PLoS One; 2016; 11(4):e0153330. PubMed ID: 27058040
[TBL] [Abstract][Full Text] [Related]
6. Changes in chromatin structure in NIH 3T3 cells induced by valproic acid and trichostatin A.
Felisbino MB; Gatti MS; Mello ML
J Cell Biochem; 2014 Nov; 115(11):1937-47. PubMed ID: 24913611
[TBL] [Abstract][Full Text] [Related]
7. Histone epigenetic marks in heterochromatin and euchromatin of the Chagas' disease vector, Triatoma infestans.
Alvarenga EM; Rodrigues VL; Moraes AS; Naves LS; Mondin M; Felisbino MB; Mello ML
Acta Histochem; 2016 May; 118(4):401-12. PubMed ID: 27079857
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure.
Ghoshal K; Datta J; Majumder S; Bai S; Dong X; Parthun M; Jacob ST
Mol Cell Biol; 2002 Dec; 22(23):8302-19. PubMed ID: 12417732
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta.
Marchion DC; Bicaku E; Turner JG; Daud AI; Sullivan DM; Munster PN
Clin Cancer Res; 2005 Dec; 11(23):8467-75. PubMed ID: 16322310
[TBL] [Abstract][Full Text] [Related]
10. Duplication and maintenance of heterochromatin domains.
Taddei A; Roche D; Sibarita JB; Turner BM; Almouzni G
J Cell Biol; 1999 Dec; 147(6):1153-66. PubMed ID: 10601331
[TBL] [Abstract][Full Text] [Related]
11. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin.
Schotta G; Lachner M; Sarma K; Ebert A; Sengupta R; Reuter G; Reinberg D; Jenuwein T
Genes Dev; 2004 Jun; 18(11):1251-62. PubMed ID: 15145825
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of histone deacetylases alter kinetochore assembly by disrupting pericentromeric heterochromatin.
Robbins AR; Jablonski SA; Yen TJ; Yoda K; Robey R; Bates SE; Sackett DL
Cell Cycle; 2005 May; 4(5):717-26. PubMed ID: 15846093
[TBL] [Abstract][Full Text] [Related]
13. Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases.
Taddei A; Maison C; Roche D; Almouzni G
Nat Cell Biol; 2001 Feb; 3(2):114-20. PubMed ID: 11175742
[TBL] [Abstract][Full Text] [Related]
14. A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.
Yu CC; Pan SL; Chao SW; Liu SP; Hsu JL; Yang YC; Li TK; Huang WJ; Guh JH
Biochem Pharmacol; 2014 Aug; 90(3):320-30. PubMed ID: 24915421
[TBL] [Abstract][Full Text] [Related]
15. The heterochromatin protein 1 (HP1) family: put away a bias toward HP1.
Kwon SH; Workman JL
Mol Cells; 2008 Sep; 26(3):217-27. PubMed ID: 18664736
[TBL] [Abstract][Full Text] [Related]
16. Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis.
Johnson CA; Padget K; Austin CA; Turner BM
J Biol Chem; 2001 Feb; 276(7):4539-42. PubMed ID: 11136718
[TBL] [Abstract][Full Text] [Related]
17. Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide.
Hajji N; Wallenborg K; Vlachos P; Füllgrabe J; Hermanson O; Joseph B
Oncogene; 2010 Apr; 29(15):2192-204. PubMed ID: 20118981
[TBL] [Abstract][Full Text] [Related]
18. Cell guidance into quiescent state through chromatin remodeling induced by elastic modulus of substrate.
Rabineau M; Flick F; Mathieu E; Tu A; Senger B; Voegel JC; Lavalle P; Schaaf P; Freund JN; Haikel Y; Vautier D
Biomaterials; 2015 Jan; 37():144-55. PubMed ID: 25453945
[TBL] [Abstract][Full Text] [Related]
19. Kinetic analysis of histone acetylation turnover and Trichostatin A induced hyper- and hypoacetylation in alfalfa.
Waterborg JH; Kapros T
Biochem Cell Biol; 2002; 80(3):279-93. PubMed ID: 12123281
[TBL] [Abstract][Full Text] [Related]
20. The changing faces of HP1: From heterochromatin formation and gene silencing to euchromatic gene expression: HP1 acts as a positive regulator of transcription.
Kwon SH; Workman JL
Bioessays; 2011 Apr; 33(4):280-9. PubMed ID: 21271610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
